At 6 weeks after injection, HMGCL depletion led to increased tumor number, size and liver weight/body ratio, as well as aspartate aminotransferase (AST) and alanine transaminase (ALT) concentration in serum (Fig. 3D, E). The gene discussed is HMGCL; the disease is neoplasm.